Proceeding contribution from Lord Alton of Liverpool (Crossbench) in the House of Lords on Tuesday, 15 January 2008. It occurred during Debate on bill on Human Fertilisation and Embryology Bill [HL].
Human Fertilisation and Embryology Bill [HL]
moved Amendment No. 8: 8: Clause 4, page 4, leave out line 11 The noble Lord said: My Lords, it was said earlier in our proceedings that the privilege of serving as Members of this House has enabled us to be on a very steep learning curve as the various stages of the Bill have taken place. I echo that remark because it is an extraordinary privilege to hear some of the contributions that have been made from learned Members of your Lordships’ House and to understand the technologies that are moving at such a galloping pace. Whether the rest of us can keep up either with the ethics or, indeed, with an understanding of those things is altogether another matter. Some of your Lordships may feel that I have laboured this point a lot. I did so in 1990 in another place when I opposed the creation of human embryos for experimental purposes; I did so in your Lordships’ House when I divided the House back in 2001 on the proposition that we should not create cloned human embryos; and, during Second Reading and, indeed, in Committee, I made clear my opposition to the creation of animal-human hybrid embryos, now to be called ““human admixed embryos”” in the legislation. The reason why I oppose those developments is not because I am opposed to good science—quite the reverse—and not because I believe that we should leave people in suffering and pain; again, quite the reverse. I think that we should make every possible progress to alleviate sickness. It is always a privilege to hear my noble friend Lord Walton of Detchant speaking about these things. There is no disagreement between us about the importance of doing all that we can to remedy disease. However, we always have to weigh in the balance the nature of what we are doing to achieve that. Sometimes I fear that the science becomes instrumentalised and that we march ahead without proper consideration to where either Parliament’s or, indeed, the public’s opinion lies on some of these things. My amendments would not affect existing animal-human embryo research such as animal transgenic and animal chimeric research, or research such as the Down’s syndrome mouse; they would simply ban the new types of interspecies embryos that would be permitted by the Bill. It is perhaps worth mentioning to your Lordships, as I did at earlier stages, that taken together the embryos that we have created since 1990—primarily for IVF cycles, but also those that we have created for experimental purposes—now number some 2.2 million. I do not think that it is unreasonable in debates of this kind for any Member of your Lordships’ House to ask how many more we need, where this science is going and what has been achieved so far. I just register the point again, as I did at an earlier stage, that so far all the scientific developments in terms of existing therapies have been achieved through adult stem cells—nearly 80 worldwide, with some 350 clinical trials under way using stem cells. There is not a single therapy, as my noble friend Lord Walton confirmed, anywhere in the world—maybe there will be, but there is not now—that uses embryonic stem cells. One of the reasons for that is often rejection. The beauty of adult stem cells is that they are taken from the patient themselves; that is why many hold that they will be the cells used in therapies in future rather than for experimental purposes, which is what the Bill permits. The Bill is therefore utterly wrong to allow licences to be granted to create true hybrids. I come back to the point that I made in my earlier intervention: we can call them ““human admixed embryos””, but a true hybrid can be 50 per cent human and 50 per cent animal as well as other kinds of human interspecies embryo. My noble and right reverend friend Lord Harries made that point earlier in his interesting comment about the difference between cytoplasmic and true hybrids in relation to these definitions. We react, quite rightly, against the notion of placing a human interspecies embryo inside a woman. That point was made eloquently by the noble Lord, Lord Winston. I agree with him: it does no one any service when they misrepresent the nature of what is being proposed. I most certainly have never suggested that we are trying to grow embryos on. This Bill explicitly forbids the growing on of human embryos, whether they are mixed or singular, into something beyond that. That is why we opposed reproductive cloning. We were united in the House about that in 2002 and I think that we are united in our opposition to the growing on of an animal-human hybrid—whatever our feelings about their initial creation—beyond the 14 days under this legislation. Why is it that we oppose that? Why would we not want to see it created? If we do not want to see it implanted, is it so lacking in logic and is it so contradictory to argue that we should not be creating it in the first place? If Members of your Lordships’ House believe that the reason for prohibiting a true hybrid from being implanted and born is that that crosses the line between human and other species, and if the problem is that this disturbs our sense of what it is to be human—a point made earlier by the most reverend Primate the Archbishop of Canterbury—we should surely, if it is so important to our common humanity and the basis of our ethics, tread very warily before permitting the creation of an animal interspecies embryo in the first place. As the elusive question about definitions stalks our debate again today, we need to ask ourselves precisely what species this embryo is. The line will have been crossed; the species will have been crossed. Among those who are looking for funding and exploring every angle, no one really believes that the long-term prospects for stem cell research lie with cybrids or these new types of interspecies embryos. This is leading us into another blind alley. It is a scientific sideshow. Our first instincts were to ban it; those were the Government’s first instincts, too, and they were the right ones. We know that this will not in the long term give us the means to get useful stem cells from adults. The noble Lord, Lord Patel, made this point just a moment ago, on the use of adult stem cells in fertility treatments. That is more likely to come from groundbreaking work from men such as Professor Shinya Yamanaka at the Institute for Frontier Medical Sciences at Kyoto University, whose breakthroughs in this area have developed even while the proceedings on this Bill have been taking place. In an interview in New Scientist on 15 December, he described how reprogrammed adult skin cells have been turned into cells akin to human embryonic stem cells. New Scientist said that, "““the method, which involves inserting genetic material that makes the cells’ development run backwards, opens the door to stem cells specific to patients, which could be used to repair damaged organs or fight diseases such as Parkinson’s and diabetes—crucially, all without the need to destroy human embryos””." That extraordinary development illustrates why, whatever the result of the vote today, the argument has been lost for investing more public money and primary legislation in such redundant techniques as making cloned interspecies embryos to try to investigate and treat disease. As we have heard, it was famously abandoned by Ian Wilmut, who produced Dolly the sheep. Last month, the journal Science reported that Professor Rudolf Jaenisch successfully treated a mouse with a humanised version of sickle cell anaemia, using induced pluripotent stem cells—that is, iPS cells. In 2002, Jaenisch attempted treating another blood disorder in mice by therapeutic cloning. The experiment failed. To cut a long story short, it worked only when adult stem cells were used. Nevertheless, it was hailed as a proof of principle for therapeutic cloning. Earlier, when my noble friend spoke movingly about spinal injuries, I was struck by what I had heard in our Moses Room a few months ago, when I organised a seminar that was attended by many noble Lords. We heard an extraordinary account—it was the basis of a BBC television programme, ““Miracle Cell””—by Professor Carlos Lima from Portugal, who has always disavowed the use of human embryonic stem cells. He told us of more than 100 treatments—not in the future, but treatments that have already taken place—using olfactory cells in the treatment of spinal injuries. He has produced real treatments; he showed us pictures to illustrate his talk. I was powerfully moved by that and I hope that my noble friend Lord Walton will have a chance to meet him in due course. Professor Jaenisch stated in the journal Cell: "““Our results raise the provocative possibility that even genetically matched cells derived by therapeutic cloning may still face barriers to effective transplantation for some disorders””." That was confirmed by Professor Ron McKay’s group, which stated in the journal Developmental Cell: "““Jaenisch addressed the possibility that ES clones derived by nuclear transfer techniques could be used to correct genetic defects … However, the donor cells, although derived from the animals with the same genetic background, are rejected by the hosts””." One proposition that we seem to agree on is that the problem with embryonic stem cells is rejection. If that is so with embryonic stem cells, I simply ask as a lay man how much more rejection there will be where we mix any degree of animal material with human material. It does not seem to be well argued from a scientific point of view, let alone an ethical one. Last month, Professor Jaenisch’s group had striking success in treating mice with iPS cells from the mice’s own skin where no similar success had been achieved using embryonic stem cells from cloned embryos. Science Express stated: "““The correction of sickle cell anaemia described in our experiments indicates that harnessing autologous iPS derived cells for therapeutic purposes recapitulates several of the promises offered previously by somatic cell nuclear transfer … This demonstrates that iPS cells have the same potential for therapy as embryonic stem cells without the ethical and practical issues raised in creating embryonic stem cells””." Most tellingly, one of Professor Jaenisch’s co-authors of the article on treating humanised sickle cell anaemia in mice, Professor Townes, commented in ScienceNOW last month that he and Jaenisch initially collaborated on a project that used nuclear transfer to make corrected stem cells; that is, therapeutic cloning. But he revealed that the experiments failed because nuclear transfer was inefficient in producing the needed cells. The iPS cell technique, Professor Townes stated, ““is amazingly efficient””. Of course, one should acknowledge that the direct reprogramming of skin cells is not going to cure everything tomorrow either, as there are still potential risks that need to be eliminated. Nevertheless, there is currently no reason to believe that such risks are any more of a barrier to future clinical use than those already apparent with embryonic stem cells. Moreover, the remarkable progress made with a technique initially reported less than two years ago clearly surpasses the claims of therapeutic cloning, for which the relevant technologies have been around for over a decade. Let me come to a conclusion. As Parliament is dazzled with misleading claims about therapies and cures, there have been none anywhere in the world. We have stubbornly refused to celebrate the life-giving qualities of adult stem cells, which are already being used and which pose none of the ethical dilemmas that this kind of legislation holds for so many of us. Instead of concentrating our efforts on their development and application through things such as the routine collection of cord blood cells, we are instead being invited to cross the Rubicon. If we permit the creation of these predominantly human interspecies embryos and full hybrids, we will be crossing an important ethical line—crossing human and animal. But for what? For the sake of a technology that we know will not be the future. As it stands, the Bill permits not only the licensing of the 99.9 per cent human cybrids that we hear so much about, but also the licensing of true hybrids, which, as the noble Lord said, may never be used but which are what this Bill provides for—50:50 hybrids, really crossing human with animal. True hybrids are the most perplexing, the most disturbing and the most extreme examples of human interspecies embryo. They are not a potential source of stem cells of obvious clinical benefit. They have no suggested clinical benefit whatsoever. A line needs to be drawn somewhere and it should be drawn to prohibit the creation of these new types of human interspecies embryo that have been proposed in the Bill. I beg to move.
Secondary information
- Type
- Proceeding contribution
- Reference
- 697 c1202-6
- Session
- 2007-08
- Chamber / Committee
- House of Lords chamber
- Subjects
- Animals Congenital abnormalities Fertility Licensing Human embryo experiments Diseases Genetics Human Fertilisation and Embryology Authority Ethics IVF Research Stem cells Human-animal hybrid embryos
- Legislation
- Human Fertilisation and Embryology Bill (HL) 2007-08
- Link
- View this Proceeding contribution on www.publications.parliament.uk
Librarians' tools
- Timestamp
- 2023-12-15 23:43:44 +0000
- URI
- http://data.parliament.uk/pimsdata/hansard/CONTRIBUTION_434353
- In Indexing
- http://indexing.parliament.uk/Content/Edit/1?uri=http://data.parliament.uk/pimsdata/hansard/CONTRIBUTION_434353
- In Solr
- https://search.parliament.uk/claw/solr/?id=http://data.parliament.uk/pimsdata/hansard/CONTRIBUTION_434353